June 19, 2013 2:15 am by Staff | 0 Comments
LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study.The companies, which jointly sell several diabetes drugs, said on Wednesday ...
Read more